SCHEMBL21550442

SCHEMBL21550442

Cc1cc(Cl)c(S(=O)(=O)Cl)c(C)c1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 5/20 0.36
▸ ALDH1A1 P00352 5/20 0.36
▸ ALOX15 P16050 4/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ PKM P14618 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MEN1 O00255 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ MAPT P10636 4/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ USP2 O75604 1/20 0.34
▸ PTGS1 P23219 3/20 0.34
▸ PTGS2 P35354 3/20 0.34
▸ ALOX5 P09917 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ HPGD P15428 2/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ SIRT1 Q96EB6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21999657 0.74 ACLY (0.42) GAAALDH1A1ALOX15HSD17B10PKM
SCHEMBL3186957 0.72 CYP3A4 (0.33) GAAALDH1A1ALOX15MEN1KMT2A
SCHEMBL30365121 0.72 CYP3A4 (0.33) GAAALDH1A1ALOX15MEN1KMT2A
SCHEMBL6379560 0.72 CA1 (0.43) GAAALDH1A1ALOX15HSD17B10TSHR
SCHEMBL27557989 0.72 SIRT1 (0.45) GAAALDH1A1ALOX15HSD17B10PKM
SCHEMBL1055918 0.71 GAA (0.47) GAAALDH1A1ALOX15HSD17B10PKM
SCHEMBL10958575 0.70 HSD17B10 (0.48) ALDH1A1ALOX15HSD17B10TSHRHPGD
SCHEMBL157574 0.70 SIRT1 (0.48) GAAALDH1A1ALOX15HSD17B10HTT
SCHEMBL4512524 0.70 CA1 (0.35) GAAALDH1A1HTTTSHRMEN1
SCHEMBL11806586 0.69 BRD4 (0.41) GAAALDH1A1HTTTSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250136545-A1 NOVEL SULFONAMIDE DERIVATIVES HAVING SELECTIVE NOX INHIBITING ACTIVITY GLUCOX BIOTECH AB (SE) 2025-05-01 — — US disclosed
US-12202790-B2 Sulfonamide derivatives having selective Nox inhibiting activity GLUCOX BIOTECH AB (SE) 2025-01-21 — — US disclosed
US-20210171456-A1 NOVEL SULFONAMIDE DERIVATIVES HAVING SELECTIVE NOX INHIBITING ACTIVITY GLUCOX BIOTECH AB (SE) 2021-06-10 — — US disclosed
EP-3790858-A1 NOVEL SULFONAMIDE DERIVATIVES HAVING SELECTIVE NOX INHIBITING ACTIVITY Glucox Biotech AB (SE) 2021-03-17 — — EP disclosed
CN-112384497-A Novel sulfonamide derivatives having selective NOX inhibitory activity 格卢科克斯生物科技有限公司 2021-02-19 — — CN disclosed
WO-2019215291-A1 NOVEL SULFONAMIDE DERIVATIVES HAVING SELECTIVE NOX INHIBITING ACTIVITY GLUCOX BIOTECH AB (SE) 2019-11-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12202790-B2 Sulfonamide derivatives having selective Nox inhibiting activity NOX4, NOX1, NOX5 GAA 411/4885ALDH1A1 493/4885ALOX15 999/4885
US-20210171456-A1 NOVEL SULFONAMIDE DERIVATIVES HAVING SELECTIVE NOX INHIBITING ACTIVITY NOX4, NOX1, NOX5 GAA 464/4885ALDH1A1 473/4885ALOX15 1076/4885
US-20250136545-A1 NOVEL SULFONAMIDE DERIVATIVES HAVING SELECTIVE NOX INHIBITING ACTIVITY NOX4, NOX1, NOX5 GAA 464/4885ALDH1A1 473/4885ALOX15 1076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback